תבנית:תרופה/לדגה - Ledaga
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | *Chlormethine AS HYDROCHLORIDE 160 MCG/G âL01AA05
|
| צ×רת ××ª× | TOPICAL |
| צ×רת ××× ×× | GEL |
| ×ת×××× | Topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/×××× - Ledaga | |
| ×ת××ת ××× ×× | Posology and method of administration |
| ×ת××××ת × ×× | Contraindications |
| ת×פע×ת ××××× | Undesirable effects |
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction |
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation |
| פר××§××§×× ×××§× | Pharmacokinetic Properties |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× | |
| ×¢××× ×צר×× | *×¢××× ×צר×× |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××× Â® ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | ACTELION PHARMACEUTICALS LTD., SWITZERLAND |
| ×©× ××¢× ×ר×ש×× | RAFA LABORATORIES LTD |
| ר×ש××× | ת×ר×× ××ש×: 08/2015. ר×ש××× ×ת×ר××: 09/2016 |
| ת×ר×× ×¢×××× ××ר×× | 14/01/19 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ×××× - Ledaga
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/×××× - Ledaga}}
×:
{{תר×פ×/×××× - Ledaga
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־14 בינואר 2019 ב־19:19